In db/db mice with type 2 diabetes, Cat-S inhibitors or PAR2 inhibitors have been reported to reduce albuminuria and glomerulosclerosis, as well as other organ complications such as diabetic retinopathy (11). This evidence concerns the gene F2RL1 and glomerulosclerosis.